BCC Research
BCC Research

10X GENOMICS

Company Snapshot

Founded: 2012
Entity Type: Public
Employees: 1,306
Region: Americas
Revenue: $610.8 Millions
Revenue Year: 2024
Headquarter: California, U.S.
Key Geographics: Americas, Europe, Middle East and Africa, Asia-Pacific

Company Overview

10x Genomics is a life sciences technology company that develops advanced tools to explore, understand, and utilize biological systems with exceptional precision and scalability. Its product portfolio includes instruments, consumables, and software designed for high-precision biological analysis. The company collaborates across disciplines such as chemistry, biology, hardware, and software, supporting research breakthroughs in fields like oncology, immunology, and neuroscience. It operates as a single business segment. 10x Genomics’ offerings are built around three core platforms: Chromium, Visium, and Xenium. The Chromium platform partitions biological samples into numerous compartments, each assigned a unique barcode to enable pooling and sequencing for high-throughput analysis. This platform provides comprehensive single-cell tissue analysis solutions with multi-omic outputs, including gene expression, protein, and chromatin profiling.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

10X GENOMICS In Reports

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

BCC Research Report: Dive into Single-Cell Genomics and Proteomics Market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

RNA Sequencing: Technologies and Global Markets

BCC Research Market Analyst says global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a CAGR of 19.1%.

Global Single-cell Technologies Market

BCC Research Market Analyst says global market for single-cell technologies is estimated to increase from $3.6 billion in 2023 to reach $9.2 billion by 2029, at a CAGR of 17.1%

View All Reports

10X GENOMICS In News

10x Genomics: Is Single Cell Sequencing Too Niche? - Nanalyze

Nanalyze - Jun 10, 2025

10x Genomics(TXG) Soars 7.88% on Strong Q1 Earnings - AInvest

AInvest - Jul 03, 2025

Pleasanton-based 10x Genomics laying off 93 local workers - Pleasanton Weekly

Pleasanton Weekly - May 28, 2025

The Single-Cell Club Is Rapidly Expanding - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Jul 07, 2025

Read All News

Company's Business Segments

  • Instruments : Chromium, Spatial.
  • Consumables : Chromium, Spatial.
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions